- Home
- CRIS vs HUBC Comparison
CRIS vs HUBC Comparison
Compare CRIS & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- HUBC
- Stock Information
- Founded
- CRIS 2000
- HUBC 2017
- Country
- CRIS United States
- HUBC Israel
- Employees
- CRIS N/A
- HUBC N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- HUBC
- Sector
- CRIS Health Care
- HUBC
- Exchange
- CRIS Nasdaq
- HUBC Nasdaq
- Market Cap
- CRIS 21.3M
- HUBC 21.7M
- IPO Year
- CRIS 2000
- HUBC N/A
- Fundamental
- Price
- CRIS $2.37
- HUBC $2.21
- Analyst Decision
- CRIS Strong Buy
- HUBC
- Analyst Count
- CRIS 2
- HUBC 0
- Target Price
- CRIS $16.50
- HUBC N/A
- AVG Volume (30 Days)
- CRIS 76.2K
- HUBC 255.5K
- Earning Date
- CRIS 07-31-2025
- HUBC 05-01-2025
- Dividend Yield
- CRIS N/A
- HUBC N/A
- EPS Growth
- CRIS N/A
- HUBC N/A
- EPS
- CRIS N/A
- HUBC N/A
- Revenue
- CRIS $11,202,000.00
- HUBC $29,562,000.00
- Revenue This Year
- CRIS $0.93
- HUBC N/A
- Revenue Next Year
- CRIS $8.10
- HUBC N/A
- P/E Ratio
- CRIS N/A
- HUBC N/A
- Revenue Growth
- CRIS 14.17
- HUBC N/A
- 52 Week Low
- CRIS $1.02
- HUBC $2.06
- 52 Week High
- CRIS $9.72
- HUBC $14.00
- Technical
- Relative Strength Index (RSI)
- CRIS 59.94
- HUBC 36.80
- Support Level
- CRIS $2.23
- HUBC $2.06
- Resistance Level
- CRIS $2.63
- HUBC $2.55
- Average True Range (ATR)
- CRIS 0.18
- HUBC 0.17
- MACD
- CRIS 0.03
- HUBC 0.02
- Stochastic Oscillator
- CRIS 67.09
- HUBC 26.69
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About HUBC Hub Cyber Security Ltd.
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.